N-omega-CD3-Octadecanoyl-D-erythro-sphingosine

CATALOG # 2201
Amount 1 mg
Price $350.00
Qty
 
N-omega-CD3-Octadecanoyl-D-erythro-sphingosine
  • Catalog #:2201
  • Scientific Name:N-omega-CD3-Octadecanoyl-D-erythro-sphingosine
  • Common Name:N-C18:0-CD3-D-erythro-Ceramide; N-Stearoyl-CD3-D-erythro-sphingosine
  • Empirical Formula:C36H68NO3D3
  • SDSView Safety Data Sheet
  • Data Sheet:View Data Sheet
  • Formula Weight:569
  • Unit:1 mg
  • Solvent:none
  • Source:synthetic
  • Purity:98+%
  • Analytical Methods:TLC, GC, identity confirmed by MS
  • Solubility:chloroform, hot ethanol, DMF
  • Physical Appearance:solid
  • Storage:-20°C
  • Dry Ice:No
  • Hazardous:No
  • Literature References:
    1. Magkos, F. and Mittendorfer, B., “Stable isotope-labeled tracers for the investigation of fatty acid and triglyceride metabolism in humans in vivo” Clin Lipidol. Vol. 4 pp. 215–230, 2009
    2. Byun, H. and Bittman, R. Selective deuterium labeling of the sphingoid backbone: facile syntheses of 3,4, 5-trideuterio-D-erythro-sphingosine and 3- deuterio-D-erythro-sphingomyelin” Chem Phys Lipids, Vol. 163(8) pp. 809-813, 2010
    3. J. M. Hauser, B. M. Buehrer, and R. M. Bell “Role of ceramide in mitogenesis induced by exogenous sphingoid bases.” Journal of Biological Chemistry Vol. 269 pp. 6803, 1994
    4. N. S. Radin, “Killing tumours by ceramide-induced apoptosis: a critique of available drugs” Biochemical Journal, Vol. 371 pp. 243-256, 2003
    5. N. S. Radin, “Designing anticancer drugs via the achilles heel: ceramide, allylic ketones, and mitochondria” Bioorganic and Medicinal Chemistry, Vol. 11(10) pp. 2123-2142, 2003